The androgen receptor (AR) nuclear transcription factor pathway is pivotal for prostate cancer development and progression, where the binding of testosterone to the AR activates downstream signalling cascades to regulate cancer cell proliferation, survival, and differentiation [3,4,5]. Here, AR is linked to prostate cancer.